Kerrisdale Advisers, LLC Ptc Therapeutics, Inc. Transaction History

Kerrisdale Advisers, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$33.9 - $47.77 $1.36 Million - $1.92 Million	-40,122 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $117,114 - $218,189	4,557 Added 12.81%	40,122 $1.35 Million
Q1 2018 May 15, 2018	BUY	$17.46 - $32.59 $9,864 - $18,413	565 Added 1.61%	35,565 $962,000
Q4 2017 Feb 14, 2018	BUY	$15.14 - $20.89 $529,900 - $731,150	35,000	35,000 $584,000

258

77.4M

179K

536K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.9B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Kerrisdale Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Kerrisdale Advisers, LLC with notifications on news.